Larimar Therapeutics/$LRMR
About Larimar Therapeutics
Ticker
Industry
Employees
LRMR Metrics
$222M
-
-$1.15
0.76
-
Price and volume
Market cap
$222M
Beta
0.76
52-week high
$13.68
52-week low
$3.01
Average daily volume
953K
Financial strength
Current ratio
13.095
Quick ratio
12.509
Long term debt to equity
2.185
Total debt to equity
2.703
Management effectiveness
Return on assets (TTM)
-28.55%
Return on equity (TTM)
-44.50%
Valuation
Price to book
1.12
Price to tangible book (TTM)
1.12
Price to free cash flow (TTM)
-3.331
Growth
Earnings per share change (TTM)
51.54%
3-year earnings per share growth (CAGR)
-30.04%
What the Analysts think about LRMR
Analyst Ratings
LRMR Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
LRMR Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
LRMR News
FAQs
What’s the current market cap for Larimar Therapeutics stock?
What is the P/E ratio for Larimar Therapeutics stock?
Does Larimar Therapeutics stock pay dividends?
No, Larimar Therapeutics (LRMR) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Larimar Therapeutics dividend payment date?
Larimar Therapeutics (LRMR) stock does not pay dividends to its shareholders.
What is the beta indicator for Larimar Therapeutics?
Larimar Therapeutics (LRMR) has a beta rating of 0.76. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.